Lindbrook Capital, LLC Boston Scientific Corp Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 5,617 shares of BSX stock, worth $488,622. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,617

Previous 5,649 0.57%

Holding current value

$488,622

Previous $435,000 8.05%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$72.96 - $84.0 $2,334 - $2,688	-32 Reduced 0.57%	5,617 $470,000
Q2 2024 Jul 31, 2024	SELL	$67.33 - $77.71 $9,695 - $11,190	-144 Reduced 2.49%	5,649 $435,000
Q1 2024 Apr 25, 2024	BUY	$57.6 - $68.62 $10,483 - $12,488	182 Added 3.24%	5,793 $396,000
Q4 2023 Jan 31, 2024	BUY	$48.64 - $57.81 $93,583 - $111,226	1,924 Added 52.18%	5,611 $324,000
Q3 2023 Oct 25, 2023	BUY	$50.19 - $54.68 $10,590 - $11,537	211 Added 6.07%	3,687 $194,000
Q2 2023 Jul 28, 2023	BUY	$49.72 - $54.64 $49 - $54	1 Added 0.03%	3,476 $188,000
Q1 2023 Apr 26, 2023	BUY	$45.09 - $50.03 $65,019 - $72,143	1,442 Added 70.93%	3,475 $173,000
Q4 2022 Jan 24, 2023	SELL	$39.56 - $47.22 $394,254 - $470,594	-9,966 Reduced 83.06%	2,033 $0
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $11,783 - $35,200	321 Added 2.75%	11,999 $465,000
Q2 2022 Aug 01, 2022	BUY	$35.24 - $47.1 $4,193 - $5,604	119 Added 1.03%	11,678 $435,000
Q1 2022 Apr 21, 2022	SELL	$40.9 - $45.1 $7,362 - $8,118	-180 Reduced 1.53%	11,559 $512,000
Q4 2021 Jan 18, 2022	BUY	$38.07 - $44.87 $3,045 - $3,589	80 Added 0.69%	11,739 $499,000
Q3 2021 Nov 05, 2021	BUY	$41.23 - $45.88 $329 - $367	8 Added 0.07%	11,659 $506,000
Q2 2021 Jul 27, 2021	BUY	$38.58 - $44.24 $1,350 - $1,548	35 Added 0.3%	11,651 $498,000
Q1 2021 Apr 28, 2021	BUY	$35.27 - $39.67 $9,276 - $10,433	263 Added 2.32%	11,616 $449,000
Q4 2020 Jan 27, 2021	BUY	$33.15 - $41.97 $530 - $671	16 Added 0.14%	11,353 $408,000
Q3 2020 Nov 03, 2020	BUY	$34.44 - $42.23 $1,446 - $1,773	42 Added 0.37%	11,337 $433,000
Q2 2020 Jul 27, 2020	SELL	$30.19 - $39.11 $9,449 - $12,241	-313 Reduced 2.7%	11,295 $397,000
Q1 2020 Apr 22, 2020	SELL	$25.83 - $45.71 $22,291 - $39,447	-863 Reduced 6.92%	11,608 $379,000
Q4 2019 Jan 27, 2020	SELL	$37.87 - $45.37 $2,082 - $2,495	-55 Reduced 0.44%	12,471 $564,000
Q3 2019 Oct 31, 2019	BUY	$40.31 - $43.45 $4,958 - $5,344	123 Added 0.99%	12,526 $510,000
Q2 2019 Jul 24, 2019	BUY	$34.91 - $42.98 $1,570 - $1,934	45 Added 0.36%	12,403 $533,000
Q1 2019 Apr 23, 2019	BUY	$32.91 - $40.75 $3,258 - $4,034	99 Added 0.81%	12,358 $474,000
Q4 2018 Feb 07, 2019	BUY	$31.73 - $39.04 $388,978 - $478,591	12,259 New	12,259 $433,000

Others Institutions Holding BSX

# of Institutions

1,537

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $125B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Boston Scientific Corp Transaction History